Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Michael Morin is active.

Publication


Featured researches published by John Michael Morin.


Tetrahedron Letters | 1986

γ-Lactam analogues of the penems

Donald B. Boyd; Thomas K. Elzey; Lowell D. Hatfield; Michael Dean Kinnick; John Michael Morin

Abstract Racemic γ-lactam analogues of the penems have been prepared and tested for biological activity. The 7-acylamino derivatives exhibited low levels of antibiotic activity.


Combinatorial Chemistry & High Throughput Screening | 2008

Ion channel screening.

John Dunlop; Mark R. Bowlby; Ravikumar Peri; Gregory Tawa; James LaRocque; Veronica Soloveva; John Michael Morin

Ion channels are attractive targets for drug discovery with recent estimates indicating that voltage and ligand-gated channels account for the third and fourth largest gene families represented in company portfolios after the G protein coupled and nuclear hormone receptor families. A historical limitation on ion channel targeted drug discovery in the form of the extremely low throughput nature of the gold standard assay for assessing functional activity, patch clamp electrophysiology in mammalian cells, has been overcome by the implementation of multi-well plate format cell-based screening strategies for ion channels. These have taken advantage of various approaches to monitor ion flux or membrane potential using radioactive, non-radioactive, spectroscopic and fluorescence measurements and have significantly impacted both high-throughput screening and lead optimization efforts. In addition, major advances have been made in the development of automated electrophysiological platforms to increase capacity for cell-based screening using formats aimed at recapitulating the gold standard assay. This review addresses the options available for cell-based screening of ion channels with examples of their utility and presents case studies on the successful implementation of high-throughput screening campaigns for a ligand-gated ion channel using a fluorescent calcium indicator, and a voltage-gated ion channel using a fluorescent membrane potential sensitive dye.


Bioorganic & Medicinal Chemistry Letters | 2000

Fused bicyclic Gly-Asp β-turn mimics with potent affinity for GPIIb-IIIa. Exploration of the arginine isostere

Matthew Joseph Fisher; Ulrich Giese; Cathy S. Harms; Michael Dean Kinnick; Terry D. Lindstrom; Jefferson R. McCowan; Hans-Jürgen Mest; John Michael Morin; Jeffrey Thomas Mullaney; Michael Paal; Achim Rapp; Gerd Ruhter; Ken J. Ruterbories; Daniel Jon Sall; Robert M. Scarborough; Theo Schotten; Wolfgang Stenzel; Richard D. Towner; Suzane L. Um; Barbara G. Utterback; Virginia L. Wyss; Joseph A. Jakubowski

6-[4-Amidinobenzoyl]amino]-tetralone-2-acetic acid is a potent antagonist of GPIIb-IIIa. Substitution in the meta position of the benzamidine, or replacement with a heteroaryl amidine was tolerated in this series. Use of an acyl-linked 4-alkyl piperidine as an arginine isostere also provided active compounds. Compounds from this series provided substantial systemic exposure in the rat following oral administration.


Heterocycles | 1990

Rearrangement of exomethylenecephams to homocephams

John Michael Morin; Douglas O. Spry; Thomas K. Elzey; Michael Dean Kinnick; Jonathan W. Paschal; Nancy June Snyder

Exomethylenecephans rearrange by reaction with diazo compounds in the presence of cupric sulfate to generaye the homocepham ring-system


Synthetic Communications | 1988

An Improved Process for the Preparation of Oxazolino-azetidinones and 1-Oxadethiacephams from Exomethylenecepham Sulfoxides

Robin D. G. Cooper; Michael Dean Kinnick; Lynn R. Peters; John Michael Morin

Abstract Oxazolino-azetidinones and 1-oxadethiacephams have been prepared in one and two steps, respectively, from exomethylene-cepham sulfoxides.


Journal of Medicinal Chemistry | 1995

Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.

Bell Fw; Amanda S. Cantrell; Marita Högberg; Jaskunas; Nils Gunnar Johansson; Christopher L. Jordan; Kinnick; Peter Thomas Lind; John Michael Morin; Rolf Noreen


Journal of Medicinal Chemistry | 1996

Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs

Amanda S. Cantrell; Per Engelhardt; Marita Högberg; S. Richard Jaskunas; Nils Gunnar Johansson; Christopher L. Jordan; Jussi Kangasmetsä; Michael Dean Kinnick; Peter Thomas Lind; John Michael Morin; M. A. Muesing; Rolf Noreen; Bo Öberg; Paul Pranc; Christer Sahlberg; Robert J. Ternansky; Lotta Vrang; and Sarah J. West; Hong Zhang


Archive | 1994

5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation.

Michael L. Denney; Matthew Joseph Fisher; Anne Marie Happ; Joseph A. Jakubowski; Michael Dean Kinnick; Jefferson R. McCowan; John Michael Morin; Daniel Jon Sall


Archive | 2003

Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes

Jochen Ammenn; James Ronald Gillig; Lawrence Joseph Heinz; Philip Arthur Hipskind; Michael Dean Kinnick; Yen-Shi Lai; John Michael Morin; James Arthur Nixon; Carsten Ott; Kenneth Allen Savin; Theo Schotten; Lawrence J. Slieker; Nancy June Snyder; Michael Alan Robertson


Archive | 1995

Method for inhibition of HIV related viruses

John Michael Morin; Robert J. Ternansky; Rolf Noreen; Tomas Lind

Collaboration


Dive into the John Michael Morin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge